{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:07:02Z","timestamp":1784261222541,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA216436"],"award-info":[{"award-number":["1R01CA216436"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA223184"],"award-info":[{"award-number":["1R01CA223184"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biomaterials.2023.122235","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T08:30:06Z","timestamp":1688200206000},"page":"122235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Co-delivery of three synergistic chemotherapeutics in a core-shell nanoscale coordination polymer for the treatment of pancreatic cancer"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8304-4938","authenticated-orcid":false,"given":"Xiaomin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0069-7541","authenticated-orcid":false,"given":"Morten J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5894-0490","authenticated-orcid":false,"given":"Taokun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langston","family":"Tillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-7759","authenticated-orcid":false,"given":"Wenbin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2023.122235_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122235_bib2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.hoc.2022.07.002","article-title":"Pancreatic adenocarcinoma: trends in epidemiology, risk factors, and outcomes","volume":"36","author":"Afghani","year":"2022","journal-title":"Hematol.\/Oncol. Clin."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122235_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","article-title":"Optimizing the outcomes of pancreatic cancer surgery","volume":"16","author":"Strobel","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10242","key":"10.1016\/j.biomaterials.2023.122235_bib4","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2023.122235_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101926","article-title":"New therapeutic targets in pancreatic cancer","volume":"81","author":"Lai","year":"2019","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.biomaterials.2023.122235_bib6","first-page":"11","article-title":"The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy","author":"Principe","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122235_bib7","first-page":"353","article-title":"Gemcitabine. New first-line therapy for pancreatic cancer","volume":"4","author":"King","year":"1996","journal-title":"Cancer Pract."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122235_bib8","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122235_bib9","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.clinthera.2017.08.015","article-title":"Current standards of chemotherapy for pancreatic cancer","volume":"39","author":"Saung","year":"2017","journal-title":"Clin. Therapeut."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122235_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrc1296","article-title":"Targeting the checkpoint kinases: chemosensitization versus chemoprotection","volume":"4","author":"Zhou","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122235_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/cancers9110157","article-title":"Pancreatic cancer chemoresistance to gemcitabine","volume":"9","author":"Amrutkar","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2023.122235_bib12","doi-asserted-by":"crossref","unstructured":"T. Koltai, S.J. Reshkin, T.M.A. Carvalho, D. Di Molfetta, M.R. Greco, K.O. Alfarouk, R.A. Cardone, Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review Cancers 14(10)(2022)2486.","DOI":"10.3390\/cancers14102486"},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122235_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1054\/drup.2000.0165","article-title":"The relevance of drug sequence in combination chemotherapy","volume":"3","author":"Shah","year":"2000","journal-title":"Drug Resist. Updates"},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122235_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology: opportunities and challenges","volume":"5","author":"Ferrari","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"19","key":"10.1016\/j.biomaterials.2023.122235_bib15","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122235_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ctrv.2007.08.001","article-title":"Novel cytotoxic drugs: old challenges, new solutions","volume":"34","author":"Ismael","year":"2008","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.biomaterials.2023.122235_bib17","series-title":"The Pancreas","first-page":"872","article-title":"Palliative chemotherapy for advanced pancreatic cancer","author":"Faluyi","year":"2018"},{"issue":"12","key":"10.1016\/j.biomaterials.2023.122235_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122235_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122235_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122235_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0169-409X(02)00226-0","article-title":"PEGylated nanoparticles for biological and pharmaceutical applications","volume":"55","author":"Otsuka","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122235_bib22","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1021\/nn500299p","article-title":"Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency","volume":"8","author":"Sykes","year":"2014","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122235_bib23","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/acsnano.6b06040","article-title":"Diverse applications of nanomedicine","volume":"11","author":"Pelaz","year":"2017","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.biomaterials.2023.122235_bib24","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1021\/ja401612x","article-title":"Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance","volume":"135","author":"Liu","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122235_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/157016309787581066","article-title":"Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect","volume":"6","author":"Sajja","year":"2009","journal-title":"Curr. Drug Discov. Technol."},{"issue":"46","key":"10.1016\/j.biomaterials.2023.122235_bib26","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem."},{"key":"10.1016\/j.biomaterials.2023.122235_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122235_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12645-019-0055-y","article-title":"Nanomedicine review: clinical developments in liposomal applications","volume":"10","author":"Beltr\u00e1n-Gracia","year":"2019","journal-title":"Cancer Nanotechnology"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122235_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122235_bib30","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharmaceut. Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122235_bib31","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/adfm.201401583","article-title":"Multiple layer-by-layer lipid-polymer hybrid nanoparticles for improved FOLFIRINOX chemotherapy in pancreatic tumor models","volume":"25","author":"Li","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2023.122235_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101733","article-title":"Biomimetic camouflaged nanoparticle-based folfirinox platform for optimizing clinical pancreatic cancer treatment","volume":"48","author":"Wang","year":"2023","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122235_bib33","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41467-019-09221-x","article-title":"Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors","volume":"10","author":"Duan","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122235_bib34","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1038\/ncomms5182","article-title":"Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy","volume":"5","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122235_bib35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0167-8140(97)01924-5","article-title":"SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids","volume":"43","author":"Omura","year":"1997","journal-title":"Radiother. Oncol."},{"issue":"12","key":"10.1016\/j.biomaterials.2023.122235_bib36","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1158\/1535-7163.MCT-06-0419","article-title":"Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells","volume":"5","author":"Lee","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.biomaterials.2023.122235_bib37","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.2c09788","article-title":"Two-stage SN38 release from a core\u2013shell nanoparticle enhances tumor deposition and antitumor efficacy for synergistic combination with immune checkpoint blockade","author":"Jiang","year":"2022","journal-title":"ACS Nano"},{"issue":"24","key":"10.1016\/j.biomaterials.2023.122235_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201614","article-title":"Tumor-activatable nanoparticles target low-density lipoprotein receptor to enhance drug delivery and antitumor efficacy","volume":"9","author":"Jiang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2023.122235_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2015.01.026","article-title":"Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer","volume":"201","author":"Poon","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2023.122235_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201614","article-title":"Tumor-activatable nanoparticles target low-density lipoprotein receptor to enhance drug delivery and antitumor efficacy","volume":"9","author":"Jiang","year":"2022","journal-title":"Adv. Sci."},{"issue":"W1","key":"10.1016\/j.biomaterials.2023.122235_bib41","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122235_bib42","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the chou-talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122235_bib43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrclinonc.2015.53","article-title":"Pancreatic cancer: from state-of-the-art treatments to promising novel therapies","volume":"12","author":"Garrido-Laguna","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3_suppl","key":"10.1016\/j.biomaterials.2023.122235_bib44","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.3_suppl.275","article-title":"Tolerability and efficacy of modified FOLFIRINOX (mFOLFIRINOX) in patients with borderline-resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAURPC)","volume":"32","author":"Blazer","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122235_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19","key":"10.1016\/j.biomaterials.2023.122235_bib46","doi-asserted-by":"crossref","first-page":"10530","DOI":"10.1021\/acs.chemrev.5b00321","article-title":"Nanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescence","volume":"115","author":"Chinen","year":"2015","journal-title":"Chem. Rev."},{"issue":"22","key":"10.1016\/j.biomaterials.2023.122235_bib47","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1021\/acs.chemrev.7b00258","article-title":"Nanotechnology for multimodal synergistic cancer therapy","volume":"117","author":"Fan","year":"2017","journal-title":"Chem. Rev."},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122235_bib48","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.addr.2007.11.009","article-title":"Polymer-drug conjugates: recent development in clinical oncology","volume":"60","author":"Li","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2023.122235_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114357","article-title":"Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment","volume":"187","author":"Tarannum","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122235_bib50","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.bjc.6602215","article-title":"Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells","volume":"91","author":"Arango","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"4 Suppl 11","key":"10.1016\/j.biomaterials.2023.122235_bib51","first-page":"3","article-title":"Gemcitabine: metabolism, mechanisms of action, and self-potentiation","volume":"22","author":"Plunkett","year":"1995","journal-title":"Semin. Oncol."},{"issue":"16","key":"10.1016\/j.biomaterials.2023.122235_bib52","first-page":"4187","article-title":"Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11","volume":"51","author":"Kawato","year":"1991","journal-title":"Cancer Res."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961223002430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961223002430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:22:33Z","timestamp":1758907353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961223002430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":52,"alternative-id":["S0142961223002430"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122235","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-delivery of three synergistic chemotherapeutics in a core-shell nanoscale coordination polymer for the treatment of pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122235"}}